THRX Share Price

Open 9.81 Change Price %
High 10.25 1 Day 0.04 0.41
Low 9.59 1 Week 0.00 0.00
Close 9.81 1 Month 0.00 0.00
Volume 668805 1 Year 0.00 0.00
52 Week High 44.62
52 Week Low 26.60
THRX Important Levels
Resistance 2 10.42
Resistance 1 10.17
Pivot 9.88
Support 1 9.45
Support 2 9.20
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
FTR 1.98 -1.98%
FTR 1.98 -1.98%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
LOCM 0.09 50.00%
SSH 2.31 32.76%
SSH 2.31 32.76%
SSH 2.31 32.76%
LTRE 2.40 31.87%
HPJ 4.90 30.67%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
ORIG 0.23 -68.49%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Theravance, Inc. (NASDAQ: THRX)

THRX Technical Analysis 1.5
As on 8th Jan 2016 THRX Share Price closed @ 9.81 and we RECOMMEND Sell for LONG-TERM with Stoploss of 13.78 & Buy for SHORT-TERM with Stoploss of 9.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
THRX Target for March
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
THRX Other Details
Segment EQ
Market Capital 2123501440.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.theravance.com
THRX Address
THRX
901 Gateway Boulevard
South San Francisco, CA 94080
United States
Phone: 650-808-6000
THRX Latest News
Innoviva, Inc. (INVA) Is Rising But Watch The Charts And Be Careful   USA Commerce Daily   - 29th Mar 17
Stock to Watch: Innoviva, Inc. (INVA)   The Oracle Examiner   - 28th Mar 17
Buy, Sell or Hold? Analysts Approach: Innoviva (INVA), Puma Biotechnology (PBYI)?   The USA Commerce   - 28th Mar 17
Comerica Bank Buys Shares of 82277 Innoviva Inc (INVA)   The Cerbat Gem   - 28th Mar 17
Stock Returns: Innoviva Inc (NASDAQ:INVA) is Beating Endo International plc ...   CML News   - 27th Mar 17
Innoviva, Inc. (INVA) : Checking the Chart   The USA Commerce   - 27th Mar 17
Innoviva Files Definitive Proxy and Sends Letter to Shareholders   Business Wire (press release)   - 22nd Mar 17
Form DFAN14A Innoviva, Inc. Filed by: Sarissa Capital Management LP   StreetInsider.com   - 20th Mar 17
Innoviva Issues Press Statement   Yahoo Finance   - 13th Mar 17
Hedge fund Sarissa seeks to replace majority of Innoviva's board   Reuters   - 07th Mar 17
Interactive Technical Analysis Chart Theravance, Inc. ( THRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Theravance, Inc.
THRX Business Profile
Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. The Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Its programs include RELVAR or BREO (fluticasone furoate/vilanterol), ANORO (umeclidinium bromide/vilanterol) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc (GSK), and its oral Peripheral Mu Opioid Receptor Antagonist program. Fluticasone Furoate/Vilanterol (FF/VI) is an investigational once-daily inhaled ICS/ LABA combination treatment, comprising fluticasone furoate (FF) and vilanterol (VI), for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD) and patients with asthma.